GRIFFIN Trial: D-RVd in Transplant-Preferred Newly Diagnosed MM – Targeted Oncology

… therapy (D-RVd). Post-induction therapy, ML achieve very good partial response (VGPR). Patient underwent stem cell mobilization and 3 months …